Immunomesh: Device to Improve Cell Production in Immunotherapy

Unmet Medical Need:  Cellular therapies hold great promise in treating cancer patients, but current T cell immunotherapy faces limitations in production and performance.

Envisioned Healthcare Product:  The envisioned device addresses key limitation of current strategies by providing a better cell expansion and improved cell production system, thus reducing the steps needed for immunotherapy production and improving the performance of the cell product.

Stage of Development:  Preliminary studies and direct comparison with the gold standard.

Collaborative Research Team:  Lance Kam PhD and Nicole Lamanna MD

Columbia-Coulter Funding Cycle: 2014-2015